AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 2,261

How often will the FTC use its recently reaffirmed authority to compel disgorgement?

K&L Gates
USA
September 6 2018

The U.S. District Court for the Eastern District of Pennsylvania recently granted the Federal Trade Commission’s (“FTC”) request to compel a branded

Federal Circuit Affirms Tribal Sovereign Immunity Does Not Apply to IPR

Marshall Gerstein & Borun LLP
USA
August 9 2018

The Federal Circuit recently affirmed the PTAB’s decision that tribal immunity cannot be asserted in an IPR (Saint Regis Mohawk Tribe v. Mylan Pharma

PTAB Upholds GILENYA Method of Treatment Patent, Prompting New ANDA Litigation

Jones Day
USA
July 30 2018

In Apotex Inc. v. Novartis AG, IPR2017-00854, Paper 109 (Jul. 11, 2018), the PTAB held that the claims of U.S. Patent No. 9,187,405 were not

Sen. Hatch on Amendment to Incentivize Generic Drug Development

Jones Day
USA
July 30 2018

As we reported in our July 2, 2018 article Hatch Bill: Restore Hatch-Waxman Balance; Limit Generics’ Access to PTAB, Senator Orrin Hatch (R-Utah), the

FDA Issues Final Guidance on Biosimilar Labeling, Sticking with Generic Model

Patterson Belknap Webb & Tyler LLP
USA
July 30 2018

Earlier this month, FDA issued final guidance on the labeling of biosimilar products. The final guidance continues the approach adopted in FDA’s March

Washington Healthcare Update - Jul 23, 2018

McGuireWoods LLP
USA
July 23 2018

The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years. The bill, H.R

Online Pharmaceuticals - Not Much Online Liability

Reed Smith LLP
USA
July 9 2018

We’ve seen stories lately that an increasing trend towards online sales of prescription drugs could become as much of a threat to retail drugstores as

House Approves Sweeping Health Care Legislation

Mintz
USA
June 25 2018

On Tuesday, June 19, 2018, the Massachusetts House of Representatives passed comprehensive health care legislation by a vote of 117-32. The bill

Washington Healthcare Update - Jun 4, 2018

McGuireWoods LLP
USA
June 4 2018

In a series of interviews during the recess week, Senate Majority Leader Mitch McConnell has described what he expects the Senate to act on. McConnell

India: Impact of proposed EU IPR enforcement mechanism on the growth of Indian generic drugs

SS Rana & Co
India
June 4 2018

India is one of the largest suppliers of low cost generic medicines in the world. The use of generic medicines, in comparison with their branded

Search techniques

Current Search

Refine

Content type

Tags